期刊文献+

艾司西酞普兰与氟西汀治疗老年期抑郁症对照研究 被引量:6

A comparative study on treatment of elderly depression with Escitaiopram and Fluoxetine
原文传递
导出
摘要 目的观察艾司西酞普兰治疗老年期抑郁症的疗效和安全性。方法采用随机对照、开放标签设计,103例老年抑郁症患者随机分到艾司西酞普兰治疗组和氟西汀治疗组,治疗8周。汉密尔顿抑郁量表(HAMD)和汉密尔顿焦虑量表(HAMA)评估患者疗效,意向治疗分析法(Intent to Treat Analysis,ITT)处理研究数据。对中途退出或失访的病例按照末次观察推进法(Last Observation Carried Forward,LOCF)处理缺失值。结果治疗8周脱落率艾司西酞普兰组低于氟西汀组,差异有统计学显著性(21%:41%,χ^2=4.82,P〈0.028);完成8周疗效观察的病例,艾司西酞普兰组有效率为90.3%;氟西汀组有效率86.6%,两组差异无统计学差异(χ^2=1.282,P=0.673);ITT分析显示两组8周时疗效显著性差异,艾司西酞普兰治疗组抑郁和焦虑症状评分改善的时间早于氟西汀组,且不良反应率低于氟西汀组。结论艾司西酞普兰治疗老年抑郁症患者疗效和耐受性均优于氟西汀。 Objective To evaluate the efficacy and safety of escitalopram in treatment of elderly patients with major depression. Methods Using randomized control and open-- label study, 103 elderly patients with depression were randomly assigned to either eseitalopram or fluoxetine group, and treated for 8 weeks. Primary outcome was measured by scores of HAMD (Hamilton Depression Scale) and HAMA (Hamilton Anxiety Scale). ITT (Intent to Treat Analysis) was used to process data and LOCF (Last Observation Carried Forward) was adopted to deal with missing value caused by withdrawing patients during 8--week observation. Results 8--weeks drop off rate of escitalopram group was lower than that of fluoxetine group, the difference was statistically significant (21% vs 41% )χ^2 = 4.82, P =0. 028). In patients who completed 8--week trail, symptom improvement rate in escitalopram group was 90.3% vs 86.6% in fluoxetine group, the difference was not statistically significant ( χ^2 = 1. 282, P = 0. 673) ; ITT analysis showed that at the end of 8-- week observation, no statistical difference in effecacy was found between two groups, while escitalopram treatment group showed earlier improvement in depression and anxiety symptom score, and rate of adverse reactions was lower than that of fluoxetine group. Conclusions Escitalopram in the treatment of elderly patients with depression has better efficacy and tolerance than fluoxetine.
出处 《神经疾病与精神卫生》 2009年第4期335-338,共4页 Journal of Neuroscience and Mental Health
关键词 艾司西酞普兰 氟西汀 老年期抑郁症 治疗 Eseitalopram Fluoxetine Elderly depression Treatment
  • 相关文献

参考文献21

  • 1Gildengers A, Houek P, Mulsant B, et al. Course and rate of antidepressant response in the very old[J]. J Affect Disord, 2002,69(1/3) : 177-184.
  • 2吴新龙,林美华,李长明,张海涛.老年抑郁的相关社会心理因素分析[J].神经疾病与精神卫生,2005,5(5):383-384. 被引量:13
  • 3Sonnenberg C, Beekman A, Deeg D,et al. Drug treatment in depressed elderly in the Dutch community[J]. Int J Geriatr Psychiatry, 2003,18 (2) : 99- 104.
  • 4Owens M, Knight D, Nemeroff C. Second- generation SSRIs : human monoamine transporter binding profile of escitalopram and R - fluoxetine[J].Biol Psychiatry, 2001,50(5) : 345- 350.
  • 5Kehoe W. Factors affecting the use and selection of antide pressants in the elderly[J]. Experimental Review of Neurotherapeutics, 2002,2 ( 1 ) : 35 - 43.
  • 6Burke WJ,Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI eseitalopram in depressed outpatients[J]. J Clin Psychiatry,2002,63(4) =331-336.
  • 7Wade A,Lemming M, H edegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care [J]. Int Clin Psyehopharmacol, 2002,17(3) :95-102.
  • 8Lepola U,Loft H,Reines E. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care[J]. Int Clin Psychopharmacol, 2003,18(4) :211-217.
  • 9Von Moltke L,Greenblatt D, Giancarlo G, et al. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes me diating biotransformation, inhibitory effects, and comparison to Rcitalopram[J]. Drug Metab Dispos, 2001,29 (8) : 1 102- 1109.
  • 10Piantadosi S. Clinical Trials, A Methodologic Perspective [M]. New York:Wiley & Sons,1997:239-210.

二级参考文献21

  • 1王玉伟,杨丽芹,孙静,邵长春.西酞普兰与氟西汀治疗抑郁症对照研究[J].临床精神医学杂志,2004,14(4):225-226. 被引量:69
  • 2林其根.老年期情感性精神病与生活事件[J].中华神经精神科杂志,1987,20:229-231.
  • 3张明园.生活事件量表常模结果[J].中国神经精神疾病杂志,1987,13(2):70-70.
  • 4Murphy E.Social Origins of Depression in Old Age.Br[J].J psychiatry,1982,141:135.
  • 5Perris H.Life Events and Personality Charateristics in Depression[J].Acta Psychiatry Scand,1984,69:350-358.
  • 6陈向一 杨德森.社会支持与医患关系[M].杨德森主编.行为医学[C].长沙:湖南师范大学出版社,1990.240-243.
  • 7Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50:345-350.
  • 8Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15:193-198.
  • 9Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45:167-173.
  • 10Sanchez C.R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model[J].Eur J Pharmacol,2003,464:155-158.

共引文献136

同被引文献61

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部